Franklin Gaylis, MD, FACS

Franklin Gaylis, MD, FACS

Genesis Healthcare Partners

San Diego, California

Franklin Gaylis, MD, FACS, is Chief Scientific Officer of Genesis Healthcare Partners (GHP), an Integrated Urology Group, and voluntary Professor of Urology at the University of California, San Diego. He received his MBBCh/MD (Cum Laude) from the University of Witwatersrand in Johannesburg, South Africa, where he graduated in the top 5% of his medical school class. After a year of basic science research, Dr. Gaylis completed his general surgical training at the University of Minnesota and his specialty training in urology at Northwestern University Medical School in Chicago, Illinois. He was nominated to the distinguished Alpha Omega Alpha Medical Honor Society at Northwestern. Dr. Gaylis is a Fellow of the American College of Surgeons and a member of the California Medical Association and American Urological Association. He is a diplomat of the American Board of Urology. He lectures nationally and internationally on the subject of medical quality. His research has been published in clinical journals such as Urology, Journal of Urology, and New England Journal of Medicine. Dr. Gaylis’ practice is focused on early and late stage prostate cancer. He actively pursues cutting-edge research on quality improvement and methods to optimize clinical outcomes. He has developed clinical tools aimed at improving outcomes following radical prostatectomy as well as reducing cost. Dr Gaylis and his team at Genesis Healthcare Partners have been awarded a Pay-for-Performance demonstration project by UnitedHealthcare to optimize the quality of active surveillance for low-risk prostate cancer. He has also developed a urinary tract dilator instrument to facilitate the efficient removal of kidney stones that has improved the safety of the procedure and has significantly reduced costs.

Disclosures:

Dr. Gaylis has an ownership stake in GenIT LLC, which owns WizMD, a software program created at Genesis Healthcare Partners that is used for data extraction. It currently has no significant value.

Articles by Franklin Gaylis, MD, FACS

Pay for Performance Model to Improve Quality of Active Surveillance in Low-Risk Prostate Cancer

In the final installment of a 3-part series, Franklin Gaylis, MD, FACS, Chief Scientific Officer of Genesis Healthcare Partners and Voluntary Professor of Urology at the University of California, San Diego, reviews measures derived from a project looking at the value of a pay for performance model in improving the quality of active surveillance in low-risk prostate cancer. He also considers the utility, simplicity, and economy of using an electronic medical record-embedded template. Dr. Gaylis concludes by suggesting that government entities and physicians should collaborate to create the best medical standards and practices possible as the US healthcare system makes the transition from volume to value.

Read More

Leveraging the EMR to Improve Quality in Clinical Practice

In part 2 of a 3-part series, Franklin Gaylis, MD, FACS, Chief Scientific Officer of Genesis Healthcare Partners and Voluntary Professor of Urology at the University of California, San Diego, shows how quality reporting improves adherence to best practices in use of active surveillance for low-risk prostate cancer. He reviews the results of a study he and his team began conducting in 2011 which showed that adoption of active surveillance for low-risk prostate cancer increased from 32% to 58% over the course of 3 years as a result of the adoption of reporting standards and reporting transparency whereby doctors could see others’ data. Since widespread adoption of active surveillance is considered a best practice, these data demonstrate how quality reporting can improve care.

Read More

Leveraging the EMR to Improve Quality in Risk Stratification for Prostate Cancer

In part 1 of a 3-part series, Franklin Gaylis, MD, FACS, Chief Scientific Officer of Genesis Healthcare Partners and Voluntary Professor of Urology at the University of California, San Diego, looks at how improved quality reporting can improve risk stratification for prostate cancer. He explains that quality reporting is expensive and time-consuming, but also necessary, and looks at how it can be improved. As an example, he considers a study by Genesis Healthcare intended to improve documentation and staging templates for digital rectal examinations (DREs) for prostate cancer staging and risk stratification. They found that by leveraging the electronic medical record (EMR) with explicit templates, they were able to increase physician confidence in DRE findings. Dr. Gaylis concludes that by encouraging urology practices to record more accurate and precise DRE information, better templates for reporting can improve patient care.

Read More

Join the GRU Community

- Why Join? -